EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
07/22/2026
Back to search
Official data from USPTO
BIOTYX MEDICAL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
41
Latest update
07/23/2026
Trademark type
Combined
Nice classes
10
Filing date
10/20/2023
Registration date
06/10/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/10/2025
Last transaction
07/23/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
99
Owner location
CN
Examiner
SEVERSON, JUSTIN
Law office
M20
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the term "BIOTYX" above the term"MEDICAL" in smaller font.
Holders and representatives
Holders
Biotyx Medical (Shenzhen) Co., Ltd.
Representatives
Nazly Aileen Bayramoglu Baryramoglu Law Offices LLC
Technical classification
Nice Classes
Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
Medical guidewires; catheters; stents; balloon catheters; artificial cardiac valves; artificial cardiac valves for surgical implantation; artificial heart valves for surgical implantation; lasers for surgical purposes; lasers for medical purposes; ablation catheters
Publications
History of USPTO decisions and trademark events.
41 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/22/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/22/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/22/2026
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/29/2026
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/10/2026
FIMP
FINAL DISPOSITION PROCESSED
01/10/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/10/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/10/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
06/10/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
05/24/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/06/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
05/06/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/22/2025
PUBO
PUBLISHED FOR OPPOSITION
04/22/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/16/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/25/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
03/25/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/25/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
03/25/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/25/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/21/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/17/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/17/2025
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
03/17/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
01/29/2025
GNFR
FINAL REFUSAL E-MAILED
01/29/2025
CNFR
FINAL REFUSAL WRITTEN
01/29/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/29/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/27/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/27/2024
RFNT
REFUSAL PROCESSED BY IB
07/20/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/01/2024
RFRR
REFUSAL PROCESSED BY MPU
06/30/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/15/2024
CNRT
NON-FINAL ACTION WRITTEN
06/11/2024
DOCK
ASSIGNED TO EXAMINER
06/05/2024
MAFR
APPLICATION FILING RECEIPT MAILED
12/22/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/18/2023
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
12/13/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/07/2023
Continuous trademark protection
Get notified about every new filing that threatens BIOTYX MEDICAL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.